Join the NJ NY RAPS Chapter for an industry update addressing the current status of the use of titanium dioxide in pharmaceuticals and the impact to formulation practices. As of October 2023, the situation regarding the use of Titanium Dioxide (TiO2) in pharmaceuticals is largely influenced by regulatory actions in the European Union (EU). The European Commission has implemented a ban on TiO2 as a food additive, primarily due to concerns over its safety as a nanomaterial. This move has raised questions about its use in pharmaceuticals.
Registration Fees & Deadlines
Member $0 | Nonmember $25
Speakers
David Schoneker
President/Owner/Regulatory & Quality Consultant, Black Diamond Regulatory Consulting, LLC
Cancellations and Refunds
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to support@raps.org. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Substitutions
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email support@raps.org with the event title, name of the original registrant and the contact information for the new attendee.
Proof of Attendance
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Questions
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email
RAPS@raps.org